These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9570458)

  • 1. Opioid receptor agonists and antagonists alter GBR12909-induced turning in the rat.
    Kimmel HL; Holtzman SG
    Eur J Pharmacol; 1998 Feb; 343(2-3):119-27. PubMed ID: 9570458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cocaine-induced motor activity in the rat by opioid receptor agonists.
    Waddell AB; Holtzman SG
    Behav Pharmacol; 1998 Sep; 9(5-6):397-407. PubMed ID: 9832925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus effects of morphine in squirrel monkeys: stimulants, opioids, and stimulant-opioid combinations.
    Platt DM; Grech DM; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1092-100. PubMed ID: 10454482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mu opioid agonists potentiate amphetamine- and cocaine-induced rotational behavior in the rat.
    Kimmel HL; Holtzman SG
    J Pharmacol Exp Ther; 1997 Aug; 282(2):734-46. PubMed ID: 9262337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor.
    Smith MA; Gordon KA; Craig CK; Bryant PA; Ferguson ME; French AM; Gray JD; McClean JM; Tetirick JC
    Psychopharmacology (Berl); 2003 May; 167(3):265-73. PubMed ID: 12669175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat.
    Baumann MH; Char GU; De Costa BR; Rice KC; Rothman RB
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1216-22. PubMed ID: 7996429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of mu-, delta-, and kappa-opioid receptor agonists on mechanosensitive gastric vagal afferent fibers in the rat.
    Ozaki N; Sengupta JN; Gebhart GF
    J Neurophysiol; 2000 Apr; 83(4):2209-16. PubMed ID: 10758129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of morphine-induced potentiation of turning and striatal dopamine release by amphetamine in the nigrally-lesioned rat.
    Kimmel HL; Justice JB; Holtzman SG
    Eur J Pharmacol; 1998 Apr; 346(2-3):203-8. PubMed ID: 9652361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the selective mu(1)-opioid receptor antagonist, naloxonazine, on cocaine-induced conditioned place preference and locomotor behavior in rats.
    Rademacher DJ; Steinpreis RE
    Neurosci Lett; 2002 Nov; 332(3):159-62. PubMed ID: 12399005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine uptake inhibitor-induced rotation in 6-hydroxydopamine-lesioned rats involves both D1 and D2 receptors but is modulated through 5-hydroxytryptamine and noradrenaline receptors.
    Lane EL; Cheetham S; Jenner P
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1124-31. PubMed ID: 15542624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone does not alter amphetamine-induced rotational behavior or striatal dopamine levels of nigrally-lesioned rats.
    Kimmel HL; Schad CA; Justice JB; Holtzman SG
    Brain Res; 1998 Apr; 789(1):171-4. PubMed ID: 9602114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, D-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice.
    Mcgeehan AJ; Janak PH; Olive MF
    Psychopharmacology (Berl); 2004 Jul; 174(2):266-73. PubMed ID: 14726993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice.
    Kuzmin A; Sandin J; Terenius L; Ogren SO
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1031-42. PubMed ID: 11082438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
    Randich A; Robertson JD; Willingham T
    Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-independent psychostimulant activity of a delta-agonist.
    Ito S; Mori T; Sawaguchi T
    Behav Pharmacol; 2008 Mar; 19(2):113-9. PubMed ID: 18332675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
    Mellon RD; Bayer BM
    Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.